Kolexia
Buisson Marlène
Pharmacien
Caisse Nationale de l'Assurance Maladie
Poitiers, France
23 Activités
77 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Méthémoglobinémie Prilocaïne Association de lidocaïne et de prilocaïne Lidocaïne Dibenzazépines Méfloquine Neuroleptiques {{person.topmesh9.name}} {{person.topmesh10.name}}

Industries

MSD
1 collaboration(s)
Dernière en 2017
Sanofi
1 collaboration(s)
Dernière en 2017
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

PICCLINIC: Analysis of the Pharmaceutical Validation of Picc Line Installation Requests at the Nîmes University Hospital
Essai Clinique (CHU Nîmes)   25 janvier 2024
Pharmaceutical Analysis of Peripherally Inserted Central Catheter Requests Increases the Use of Single-Lumen Catheters: A Prospective Pilot Study.
Journal of patient safety   02 août 2022
A new clinical approach to improve the appropriate use of peripherally inserted central catheters: a prospective study.
European journal of hospital pharmacy : science and practice   07 janvier 2021
Health economic evaluation of a clinical pharmacist's intervention on the appropriate use of devices and cost savings: A pilot study.
International journal of surgery (London, England)   29 août 2020
Lidocaine/prilocaine-induced methemoglobinemia: particular risk of inappropriate use in infants
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, and INSERM Clinical Research Centers (CIC) Meeting, 12–14 June 2019, Lyon, France   05 juin 2019
A case report of mefloquine-induced neuropsychiatric disorders in a 13-month-old child
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, and INSERM Clinical Research Centers (CIC) Meeting, 12–14 June 2019, Lyon, France   05 juin 2019
Hepatotoxicity induced by antipsychotic agents belonging to the dibenzazepine family: a cumulative toxicity?
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, and INSERM Clinical Research Centers (CIC) Meeting, 12–14 June 2019, Lyon, France   05 juin 2019
{{person.lastact8.name}}
{{person.lastact8.jour}}   {{person.lastact8.date}}
{{person.lastact9.name}}
{{person.lastact9.jour}}   {{person.lastact9.date}}
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}